CONTEXT: Rare mutations in APOB cause hypercholesterolemia. Whether common polymorphisms in APOB have similar effects remains controversial. OBJECTIVE: We tested the hypothesis that the APOB 7673C>T polymorphism (T2488T) is associated with variation in low-density lipoprotein (LDL) levels and with risk of ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), and total mortality in the general population. DESIGN: The design was a cohort study with 22-yr follow-up (166,232 person years) and two case-control studies, The Copenhagen City Heart Study. SETTINGS: The study was performed within the Danish general population and at a university hospital. PARTICIPANTS: The study was comprised of 9185 individuals from the general population, 2157 patients with IHD, and 378 patients with ICVD. MAIN OUTCOME MEASURES: The main outcome measures were lipids, lipoproteins, apolipoproteins (apo), IHD, ICVD, and total mortality. RESULTS: Genotype was associated with increases in total cholesterol (women/men), LDL cholesterol, and apoB of 0.20/0.26 mmol/liter (3.3%/4.4%), 0.22/0.28 mmol/liter (5.9%/7.8%), and 5.0/5.6 mg/dl (5.9%/6.7%) in TT vs. CC homozygotes, respectively. These results were consistent over time. Despite this, the 7673C>T polymorphism was not associated with risk of IHD, ICVD, or total mortality prospectively or in case-control studies. CONCLUSION: The APOB 7673C>T polymorphism is associated with moderate increases in total cholesterol, LDL cholesterol, and apoB in both genders in the general population, but not with risk of IHD, ICVD, or total mortality.
CONTEXT: Rare mutations in APOB cause hypercholesterolemia. Whether common polymorphisms in APOB have similar effects remains controversial. OBJECTIVE: We tested the hypothesis that the APOB 7673C>T polymorphism (T2488T) is associated with variation in low-density lipoprotein (LDL) levels and with risk of ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), and total mortality in the general population. DESIGN: The design was a cohort study with 22-yr follow-up (166,232 person years) and two case-control studies, The Copenhagen City Heart Study. SETTINGS: The study was performed within the Danish general population and at a university hospital. PARTICIPANTS: The study was comprised of 9185 individuals from the general population, 2157 patients with IHD, and 378 patients with ICVD. MAIN OUTCOME MEASURES: The main outcome measures were lipids, lipoproteins, apolipoproteins (apo), IHD, ICVD, and total mortality. RESULTS: Genotype was associated with increases in total cholesterol (women/men), LDL cholesterol, and apoB of 0.20/0.26 mmol/liter (3.3%/4.4%), 0.22/0.28 mmol/liter (5.9%/7.8%), and 5.0/5.6 mg/dl (5.9%/6.7%) in TT vs. CC homozygotes, respectively. These results were consistent over time. Despite this, the 7673C>T polymorphism was not associated with risk of IHD, ICVD, or total mortality prospectively or in case-control studies. CONCLUSION: The APOB 7673C>T polymorphism is associated with moderate increases in total cholesterol, LDL cholesterol, and apoB in both genders in the general population, but not with risk of IHD, ICVD, or total mortality.
Authors: K M Steffen; M E Cooper; M Shi; D Caprau; H N Simhan; J M Dagle; M L Marazita; J C Murray Journal: J Perinatol Date: 2007-09-13 Impact factor: 2.521
Authors: Rishika De; Shefali S Verma; Emily Holzinger; Molly Hall; Amber Burt; David S Carrell; David R Crosslin; Gail P Jarvik; Helena Kuivaniemi; Iftikhar J Kullo; Leslie A Lange; Matthew B Lanktree; Eric B Larson; Kari E North; Alex P Reiner; Vinicius Tragante; Gerard Tromp; James G Wilson; Folkert W Asselbergs; Fotios Drenos; Jason H Moore; Marylyn D Ritchie; Brendan Keating; Diane Gilbert-Diamond Journal: Hum Genet Date: 2016-11-15 Impact factor: 4.132
Authors: Christina Christoffersen; Marianne Benn; Pernille M Christensen; Philip L S M Gordts; Anton J M Roebroek; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Björn Dahlbäck; Lars B Nielsen Journal: J Lipid Res Date: 2012-07-23 Impact factor: 5.922
Authors: Blake E Haas; Daphna Weissglas-Volkov; Carlos A Aguilar-Salinas; Elina Nikkola; Laurent Vergnes; Ivette Cruz-Bautista; Laura Riba; Alena Stancakova; Johanna Kuusisto; Pasi Soininen; Antti J Kangas; Mika Ala-Korpela; Teresa Tusie-Luna; Markku Laakso; Päivi Pajukanta Journal: Arterioscler Thromb Vasc Biol Date: 2011-03-10 Impact factor: 8.311
Authors: Viktor Hamrefors; Marju Orho-Melander; Ronald M Krauss; Bo Hedblad; Peter Almgren; Göran Berglund; Olle Melander Journal: J Lipid Res Date: 2009-09-22 Impact factor: 5.922
Authors: Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander Journal: Nat Genet Date: 2008-01-13 Impact factor: 38.330
Authors: Mary E Keebler; Christopher L Sanders; Aarti Surti; Candace Guiducci; Noel P Burtt; Sekar Kathiresan Journal: Circ Cardiovasc Genet Date: 2009-04-14
Authors: Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang Journal: Int J Biol Sci Date: 2009-06-29 Impact factor: 6.580